» Authors » Craig M Kessler

Craig M Kessler

Explore the profile of Craig M Kessler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 85
Citations 1617
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
McKeown W, Hermans C, Unzu C, Kay M, Peyvandi F, Smith P, et al.
Haemophilia . 2025 Jan; PMID: 39868975
Introduction: Gene editing therapies offer the possibility of substantial improvement in treatment and quality of life for people with haemophilia (PWH) in a landscape of dynamic therapeutic advancement. Developing a...
2.
Goldenberg N, Schulman S, Kittelson J, Abshire T, Casella J, Dale R, et al.
J Thromb Haemost . 2024 Oct; 23(2):651-656. PMID: 39461724
Background: The Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children multinational, randomized clinical trial revealed noninferiority of a 6-week vs 3-month duration of anticoagulation for the treatment...
3.
Poston J, Bryan C, von Drygalski A, Al Banaa K, Zhou J, Parnes A, et al.
Blood Adv . 2024 Oct; 8(22):5896-5905. PMID: 39361769
Acquired hemophilia A (AHA) is an autoimmune bleeding disorder that is caused by factor VIII (FVIII) autoantibodies with high morbidity and mortality due to bleeding and complications from immunosuppression (IST)....
4.
Tiu A, McKinnell Z, Liu S, Gill P, Antonio M, Shancer Z, et al.
Am J Hematol . 2024 Jul; 99(10):1969-1978. PMID: 39023278
The Promise to Address Comprehensive Toxics (PACT) Act expanded U.S. Veterans' health care and benefits for conditions linked to service-connected exposures (e.g., Burn Pits, Agent Orange). However, myeloproliferative neoplasms (MPN)...
5.
Mammen E, Comp P, Gosselin R, Greenberg C, Hoots W, Kessler C, et al.
Semin Thromb Hemost . 2023 Dec; 50(4):664-671. PMID: 38092024
This is a celebratory reprint of a historical paper published in STH in 1998. The original Abstract follows.The PFA-100 system is a platelet function analyzer designed to measure platelet-related primary...
6.
Hay C, Makris M, Shima M, Nagao A, Jimenez-Yuste V, Skinner M, et al.
Haemophilia . 2023 Nov; 30(1):106-115. PMID: 38030962
Introduction: Patient-reported outcomes (PROs) in people living with haemophilia A (PLWHA) are often under-reported. Investigating PROs from a single study with a diverse population of PLWHA is valuable, irrespective of...
7.
Alcedo Andrade P, Mannucci P, Kessler C
Haematologica . 2023 Nov; 109(5):1334-1347. PMID: 37916312
In hemophilia, the unmet needs regarding adherence to prophylaxis and lack of effective long-term prophylaxis regimens, especially in patients with inhibitors, led to the production of emicizumab, the first non-factor...
8.
Kessler C, Corrales-Medina F, Mannucci P, Jimenez-Yuste V, Tarantino M
Eur J Haematol . 2023 Aug; 111(5):757-767. PMID: 37587687
Objectives: We aimed to indirectly compare the efficacy of personalized prophylaxis with simoctocog alfa (Nuwiq®) versus three extended half-life (EHL) recombinant FVIII (rFVIII) concentrates. Methods: Treatment effects were compared using...
9.
Pipe S, Trzaskoma B, Minhas M, Lehle M, Ko R, Gao L, et al.
Res Pract Thromb Haemost . 2023 Aug; 7(4):100191. PMID: 37538504
[This corrects the article DOI: 10.1016/j.rpth.2023.100077.].
10.
Mannucci P, Kessler C, Germini F, Nissen F, Ofori-Asenso R, Brocchieri C, et al.
Haemophilia . 2023 Jun; 29(4):954-962. PMID: 37289855
Background: Evidence on bleeding rates in people with congenital haemophilia A (PwcHA) without inhibitors on factor VIII (FVIII) replacement products is inconsistent. Aim: This systematic literature review assessed bleeding outcomes...